Yvonne Greenstreet - Net Worth and Insider Trading
Yvonne Greenstreet Net Worth
The estimated net worth of Yvonne Greenstreet is at least $19 Million dollars as of 2024-12-27. Yvonne Greenstreet is the CEO of Alnylam Pharmaceuticals Inc and owns about 79,287 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $19 Million. Details can be seen in Yvonne Greenstreet's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yvonne Greenstreet has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yvonne Greenstreet
Yvonne Greenstreet Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yvonne Greenstreet owns 3 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Pacira BioSciences Inc (PCRX) , and Moelis & Co (MC) .
Click here to see the complete history of Yvonne Greenstreet’s form 4 insider trades.
Insider Ownership Summary of Yvonne Greenstreet
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2024-11-26 | EVP & Chief Commercial Officer |
PCRX | Pacira BioSciences Inc | 2014-03-04 | director |
MC | Moelis & Co | 2015-02-19 | director |
Yvonne Greenstreet Latest Holdings Summary
Yvonne Greenstreet currently owns a total of 1 stock. Yvonne Greenstreet owns 79,287 shares of Alnylam Pharmaceuticals Inc (ALNY) as of November 26, 2024, with a value of $19 Million.
Latest Holdings of Yvonne Greenstreet
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2024-11-26 | 79,287 | 242.50 | 19,227,098 |
Holding Weightings of Yvonne Greenstreet
Yvonne Greenstreet Form 4 Trading Tracker
According to the SEC Form 4 filings, Yvonne Greenstreet has made a total of 14 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 5,219 shares on November 26, 2024, which brought Yvonne Greenstreet around $1 Million.
Insider Trading History of Yvonne Greenstreet
- 1
Yvonne Greenstreet Trading Performance
Yvonne Greenstreet Ownership Network
Yvonne Greenstreet Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Yvonne Greenstreet is the EVP & Chief Commercial Officer of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include CMO & EVP Dev & Med Affairs Pushkal Garg , EVP & Chief Commercial Officer Tolga Tanguler , and Chief Financial Officer Jeffrey V. Poulton .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Yvonne Greenstreet made 7 insider transaction in Alnylam Pharmaceuticals Inc (ALNY) with a net sale of 57,750. Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 13,738 shares made by Pushkal Garg , a net sale of 7,321 shares made by Jeffrey V. Poulton , and a net sale of 26,223 shares made by Kevin Joseph Fitzgerald .
In summary, during the past 3 months, insiders sold 14,804 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 14,804 shares. During the past 18 months, 263,932 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 263,932 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Yvonne Greenstreet Mailing Address
Above is the net worth, insider trading, and ownership report for Yvonne Greenstreet. You might contact Yvonne Greenstreet via mailing address: Pacira Pharmaceuticals, Inc., 5 Sylvan Way, Parsippany Nj 07054.